Fig. 3From: The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advancesManufacturing engineered CAR-NK cells for clinical applications.Created with BioRender.comBack to article page